Marimed (MRMD) Intangibles (2017 - 2026)
Marimed's (MRMD) quarterly Intangibles came in at $16.4 million in Q1 2026, down 24.39% year-on-year from $21.7 million in Q1 2025, and down 4.71% on a QoQ basis from $17.2 million in Q4 2025.
Marimed (MRMD) Intangibles (2017 - 2026) Analysis & Trends
Marimed (MRMD) has 10 years of Intangibles data on file, last reported at $16.4 million in Q1 2026.
- On a quarterly basis, Intangibles fell 24.39% year-over-year to $16.4 million in Q1 2026; TTM through Mar 2026 was $16.4 million, a 24.39% decrease from a year earlier, with the FY2025 full-year figure at $17.2 million, down 7.67% from the prior year.
- Intangibles for Q1 2026 stood at $16.4 million, down from $17.2 million in the prior quarter.
- Over the last five years, Intangibles for MRMD reached as high as $21.7 million in Q1 2025 and fell as low as $1.4 million in Q3 2025.
- Historically, Intangibles has averaged $15.2 million across 5 years, with a median of $17.2 million in 2025.
- Across the five-year window, Intangibles soared 8666.05% in 2022 and plunged 92.82% in 2025, its largest moves.
- Year by year, Intangibles stood at $14.2 million in 2022, then increased by 19.79% to $17.0 million in 2023, then rose by 9.56% to $18.6 million in 2024, then dropped by 7.67% to $17.2 million in 2025, then dropped by 4.71% to $16.4 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $16.4 million in Q1 2026, $17.2 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | 16.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.40 Mn |
| Dec 31, 2025 | 17.21 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 20.72 Mn |
| Mar 31, 2025 | 21.69 Mn |
| Dec 31, 2024 | 18.64 Mn |
| Sep 30, 2024 | 19.52 Mn |
| Jun 30, 2024 | 20.40 Mn |
| Mar 31, 2024 | 12.82 Mn |
| Dec 31, 2023 | 17.01 Mn |
| Sep 30, 2023 | 17.86 Mn |
| Jun 30, 2023 | 18.70 Mn |
| Mar 31, 2023 | 19.48 Mn |
| Dec 31, 2022 | 14.20 Mn |
| Sep 30, 2022 | 9.47 Mn |
| Jun 30, 2022 | 9.90 Mn |
| Mar 31, 2022 | 2.40 Mn |
| Dec 31, 2021 | 162,000.00 |
| Sep 30, 2021 | 2.35 Mn |
| Jun 30, 2021 | 2.52 Mn |